Insider Transactions in Q1 2025 at Sellas Life Sciences Group, Inc. (SLS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2025
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
194,300
+27.77%
|
-
|
|
Jan 10
2025
|
Dragan Cicic SVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
194,300
+26.95%
|
-
|
|
Jan 10
2025
|
John Varian Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+35.31%
|
-
|
|
Jan 10
2025
|
Katherine Bach Kalin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+37.31%
|
-
|
|
Jan 10
2025
|
Robert L Van Nostrand Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+35.31%
|
-
|
|
Jan 10
2025
|
Jane Wasman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+35.31%
|
-
|
|
Jan 10
2025
|
David A Scheinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+35.13%
|
-
|
|
Jan 10
2025
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
500,900
+25.79%
|
-
|